Figure 2 | Scientific Reports

Figure 2

From: Predictive assessment in pharmacogenetics of XRCC1 gene on clinical outcomes of advanced lung cancer patients treated with platinum-based chemotherapy

Figure 2

Forest plots of clinical outcomes in advanced lung cancer patients treated with platinum-based chemotherapy by the XRCC1 Arg194Trp polymorphism.

(A) Odds ratios (ORs) (and its 95% confidence interval (CI)) of objective response rate (ORR) stratified by study quality levels for TrpTrp+TrpArg vs. ArgArg. (B). Hazard ratios (HRs) (and its 95% CI) of overall survival (OS) for TrpTrp vs. ArgArg. (C). HRs (and its 95% CI) of median progression-free survival (PFS) for TrpTrp vs. ArgArg.

Back to article page